According to the results of a single-center, prospective, crossover study, darbepoetin alfa—a hyperglycosylated, and therefore longer-acting, derivative of epoetin—is a more effective ...

We did not control for this potential confounder, since our focus was on hospitalwide use of darbepoetin and epoetin, regardless of the clinical outcomes directly related to their use. Another ...

This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...

Darbepoetin alfa 10mcg/0.4mL, 25mcg/0.42mL, 40mcg/0.4mL, 60mcg/0.3mL, 100mcg/0.5mL, 150mcg/0.3mL, 200mcg/0.4mL, 300mcg/0.6mL, 500mcg/mL; per prefilled syringe; for IV ...

MK-2578, in phase 2 trials, was Merck's most advanced biosimilar—similar to Amgen's blockbuster Aranesp (darbepoetin alfa). “Other biosimilars counterparts will have to face [similarly] strict ...